MetLife announces USD 3 billion buyback for MetLife stock

Published on 10/20/2026 at 10:50 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

MetLife's second-quarter adjusted earnings rose 15 percent to USD 1.6 billion on October 9, 2026. MetLife stock has results due November 4, 2026.

MetLife strengthens capital returns

MetLife authorized USD 3 billion in share repurchases on October 9, 2026.
Group Benefits adjusted earnings reached USD 503 million in the second quarter of 2026.
MetLife stock traded at EUR 88.73 at 10:42 a.m. CEST at Lang & Schwarz on October 20, 2026.
Third-quarter results are scheduled for November 4, 2026.

Dokumentarische Schwarzweiß-Aufnahme einer Familie bei der Vertragsunterzeichnung am Tisch — Schwarzweiß-Reportagefoto einer Familie bei Versicherungsberatung, thematisch verbunden mit MetLife Inc., ISIN US59156R1086, Illustration mit AI erstellt.

MetLife Inc. (US59156R1086) authorized a USD 3 billion share repurchase program as adjusted second-quarter earnings rose 15 percent to USD 1.6 billion. The capital return decision and results were discussed in the company's October 9, 2026 earnings call, reported by Benzinga.

Buyback follows broad earnings growth

The second-quarter performance extended beyond the headline adjusted earnings figure. Adjusted earnings per share increased 20 percent year over year to USD 2.43, while net income totaled USD 705 million, or USD 1.09 per share, for the same period, according to Benzinga.

MetLife also repurchased approximately USD 700 million of common shares during the quarter. Through July, the insurer had returned more than USD 2.4 billion to shareholders through buybacks and common dividends, the earnings-call transcript said.

What does the operating mix show?

Group Benefits was the clearest operating contributor in the second quarter of 2026. Its adjusted earnings rose 25 percent year over year to USD 503 million, while the group life mortality ratio was 79 percent, below the company's 2026 target range of 83 percent to 88 percent, according to Zacks.

The chronology is clear. On September 22, 2026, Piper Sandler upgraded MetLife to Overweight from Neutral and raised its target from USD 99.00 to USD 110.00, as reported by Investing.com. On October 9, 2026, MetLife reported second-quarter adjusted earnings of USD 1.6 billion and announced the USD 3 billion authorization. On October 13, 2026, the stock reached USD 101.01 in the US market, according to Investing.com.

Next date is November 4

MetLife is scheduled to report third-quarter 2026 results on November 4, 2026, according to Gekko. The upcoming report will test whether the favorable Group Benefits underwriting trend can offset the earnings volatility typical of investment income.

Stock price and capital returns

At Lang & Schwarz, MetLife stock was trading intraday at EUR 88.73 on October 20, 2026 at 10:42 a.m. CEST. The quoted euro price provides the market snapshot while the latest operating picture rests on the second-quarter figures and the new repurchase authorization.

The further course of trading is shown by the continuously updated real-time quote of MetLife stock.